Company intelligence / Profile preview

Wall Street Equities

New York, New York, USA

Ownership: Private
Development stage: Other

Overview

Wall Street Equities is a financial research firm that provides equity reports and market analysis, with a significant focus on the healthcare and biotechnology sectors. The company offers technical and fundamental analysis of publicly traded life science companies to assist investors in navigating the complexities of the biotech market. Its services include monitoring clinical trial progress, regulatory milestones, and financial performance of major and emerging pharmaceutical firms. The firm aims to bridge the information gap for retail and institutional investors by delivering timely updates on market trends and stock ratings.

Industry: Consulting

Beyond the preview

Go deeper on Wall Street Equities.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wall Street Equities.

Explore the full profile